This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

As part of the implementation of the ISO IDMP requirements in combination with the EU IG, it will be possible to enter marketing information per pack line from 06.12.2023.

#MedSafetyWeek from November 6 to 12, 2023 - Reporting suspected adverse drug reactions helps to improve the safety of medicines. In a joint "MedSafetyWeek" campaign, pharmaceutical authorities around the world are reminding people how important it is to report suspected cases of adverse drug reactions. This year's campaign focuses on the important role of healthcare professionals and patients, who contribute to the safety of medicines by reporting suspected side effects.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

CHESSMEN Board meets in Rome to discuss shortage prevention.

BASG informs about current developments and necessary measures in case of counterfeiting of the medicinal product Ozempic® in German presentation.

On Friday 18.8.2023 a delegation of the Chinese Drug Administration Zhejiang Medical Products Administration visited the AGES Medical Market Surveillance for an exchange and deeper insights into the fields of activity.

10 years after the review of iron-containing drugs for intravenous use associated with allergic reactions, cautions are recalled.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

New recommendations for the composition of seasonal influenza vaccines for the season 2023/2024 adopted.